Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial

Russell, Nigel, Burnett, Alan, Hills, Robert ORCID: https://orcid.org/0000-0003-0166-0062, Betteridge, Sophie, Dennis, Mike, Jovanovic, Jelena, Dillon, Richard and Grimwade, David 2018. Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial. Blood 132 (13) , pp. 1452-1454. 10.1182/blood-2018-05-851824

Preview

PDF - Accepted Post-Print Version Download (285kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR)
Publisher:	American Society of Hematology
ISSN:	0006-4971
Date of First Compliant Deposit:	18 October 2018
Date of Acceptance:	10 August 2018
Last Modified:	17 Nov 2024 10:00
URI:	https://orca.cardiff.ac.uk/id/eprint/115744

Citation Data

Cited 33 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item